Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs) are steroid hormones that exert important physiological actions on metabolism. Given that GCs also exert potent immunosuppressive and anti-inflammatory actions, synthetic GCs such as prednisolone and dexamethasone were developed for the treatment of autoimmune- and inflammatory-related diseases. The synthetic GCs are undoubtedly efficient in terms of their therapeutic effects, but are accompanied by significant adverse effects on metabolism, specifically glucose metabolism. Glucose intolerance and reductions in insulin sensitivity are among the major concerns related to GC metabolic side effects, which may ultimately progress to type 2 diabetes mellitus. A number of pre-clinical and clinical studies have aimed to understand the repercussions of GCs on glucose metabolism and the possible mechanisms of GC action. This review intends to summarize the main alterations that occur in liver, skeletal muscle, adipose tissue, and pancreatic islets in the context of GC-induced glucose intolerance. For this, both experimental (animals) and clinical studies were selected and, whenever possible, the main cellular mechanisms involved in such GC-side effects were discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 8×
“Previous Metabolites 2016, 6, 24 14 of 21 metabolic susceptibility such as that observed in obese, metabolic syndrome and T2DM patients must be taken into account.”
BackgroundInfluentialDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“These morphological changes in the liver may be due to indirect effects of GCs stimulating lipolysis to elevate circulating FFA levels [75,76], or because of de novo lipogenesis in the liver itself from elevated glucose concentrations [74] (Figure 1).”
BackgroundKern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 1×
“Both plasma TNF-α and IL-6 are associated with hyperinsulinemia [94] and reduced levels have been found to improved insulin sensitivity.”
BackgroundMechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Adipose-specific 11β-HSD1 over-expression in mice (in subcutaneous and epididymal depots) results in obesity and IR in mice [85], whereas inhibiting 11β-HSD1 enhanced adipose insulin sensitivity [86].”
BackgroundKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 1×
“Thus, changes in the peripheral insulin sensitivity are reciprocally compensated by changes in circulating insulin levels [98,99].”
BackgroundMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“Samuel and Colleagues [80] suggested that PKCε might target the c-Jun N-terminal kinase (JNK)-1 to influence hepatic insulin resistance, although more research is required to determine if there is a connection between the two.”
Background11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · cited 1×
“11β-HSD1 is expressed in insulin-target tissues including liver, adipose, and muscles as well as modulating the tissue GC availability [50].”
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 3×
“Their central and peripheral actions are well characterized in pathologic conditions of excessive GC secretion, such as in Cushing’s Syndrome, or during GC deficiency, as in Addison’s disease [1,2].”
BackgroundMorton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · cited 1×
“Adipose-specific 11β-HSD1 over-expression in mice (in subcutaneous and epididymal depots) results in obesity and IR in mice [85], whereas inhibiting 11β-HSD1 enhanced adipose insulin sensitivity [86].”
Background
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Li, H., Cai, J., Chen, R., Zhao, Z., Ying, Z., Wang, L., Chen, J., Hao, K., Kinney, P. L., Chen, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026796 · Cited by 521
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
Polydeoxyribonucleotide Regulation of Inflammation
Colangelo, M. T., Galli, C., & Guizzardi, S. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1031 · Cited by 33
Jiang, R., Wang, M., Shi, L., Zhou, J., Ma, R., Feng, K., Chen, X., Xu, X., Li, X., Li, T., et al. (2019) · BioMed Research International · doi:10.1155/2019/3719643 · Cited by 27
“However, excess DEX leads to defects in glucose metabolism, muscle atrophy, and insulin resistance [4, 5].”
Background
Metadata
- Authors
- Pasieka, A., & Rafacho, A.
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2016-08-03
- Volume
- 6
- Issue
- 3
- Pages
- 24
- ISSN
- 2218-1989 (ISSN-L)
- OpenAlex
- W2485845712
- Cited by
- 90
- References
- 42
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence. https://app.cochat.ai/papers/10.3390/metabo6030024
- The paper
- Pasieka, A., & Rafacho, A. (2016). Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence. Metabolites. https://doi.org/10.3390/metabo6030024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.